The House Health Care Committee is looking for ways to bring down the cost of prescription drugs.

The committee took testimony Wednesday on a bill that would require state health care regulators to collect information from prescription drug manufacturers on what drives their prices.

Proponents say the bill, H.866, would force pharmaceutical companies to release information they never have before. Once regulators have the information in hand, supporters hope, they could use it to drive down prices.

Vermont is one of a handful of states, including New York, California, Massachusetts and Minnesota, to consider such a law. Rep. Chris Pearson, P-Burlington, has taken the lead on the bill and says he hopes to put pressure on Congress to do something about drug prices.

Continue reading here.